Skip to content
10-Q

Quarterly Report

CADENCE PHARMACEUTICALS INC

0001193125-13-317203

← back to feed
Filed
Aug 2, 2013 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2013 · Jul 31, 2013 86.07M sh
Capex Q2 2013 · Jun 30, 2013 $62K
Capex Q2 2013 · Jun 30, 2012 $1.22M
Operating Cash Flow Q2 2013 · Jun 30, 2013 −$20.67M
Operating Cash Flow Q2 2013 · Jun 30, 2012 −$35.35M
Long Term Debt Q2 2013 · Jun 30, 2013 $23.87M
Long Term Debt Q2 2013 · Dec 31, 2012 $28.82M
Short Term Debt Q2 2013 · Jun 30, 2013 $5.2M
Cash And Equivalents Q2 2013 · Jun 30, 2013 $54.48M
Cash And Equivalents Q2 2013 · Dec 31, 2012 $58.33M
Cash And Equivalents Q2 2013 · Jun 30, 2012 $86.99M
Cash And Equivalents Q2 2013 · Dec 31, 2011 $82.61M
Stockholders Equity Q2 2013 · Jun 30, 2013 $38.9M
Stockholders Equity Q2 2013 · Dec 31, 2012 $47.81M
Current Liabilities Q2 2013 · Jun 30, 2013 $26.36M
Current Liabilities Q2 2013 · Dec 31, 2012 $21M
Total Liabilities Q2 2013 · Jun 30, 2013 $50.65M
Total Liabilities Q2 2013 · Dec 31, 2012 $49.87M
Current Assets Q2 2013 · Jun 30, 2013 $76.15M
Current Assets Q2 2013 · Dec 31, 2012 $76.52M
Total Assets Q2 2013 · Jun 30, 2013 $89.55M
Total Assets Q2 2013 · Dec 31, 2012 $97.68M
Sga Expense Q2 2013 · Jun 30, 2013 $25.7M
Sga Expense Q2 2013 · Jun 30, 2013 $47.33M
Sga Expense Q2 2013 · Jun 30, 2012 $23.24M
Sga Expense Q2 2013 · Jun 30, 2012 $46.77M
Rd Expense Q2 2013 · Jun 30, 2013 $1.68M
Rd Expense Q2 2013 · Jun 30, 2013 $3.04M
Rd Expense Q2 2013 · Jun 30, 2012 $1.7M
Rd Expense Q2 2013 · Jun 30, 2012 $3.21M
Net Income Q2 2013 · Jun 30, 2013 −$11.88M
Net Income Q2 2013 · Jun 30, 2013 −$13.24M
Net Income Q2 2013 · Jun 30, 2012 −$20.99M
Net Income Q2 2013 · Jun 30, 2012 −$43.66M
Operating Income Q2 2013 · Jun 30, 2013 −$10.79M
Operating Income Q2 2013 · Jun 30, 2013 −$18.73M
Operating Income Q2 2013 · Jun 30, 2012 −$19.93M
Operating Income Q2 2013 · Jun 30, 2012 −$41.55M
Cost Of Revenue Q2 2013 · Jun 30, 2013 $8.29M
Cost Of Revenue Q2 2013 · Jun 30, 2013 $16.46M
Cost Of Revenue Q2 2013 · Jun 30, 2012 $5.76M
Cost Of Revenue Q2 2013 · Jun 30, 2012 $10M
Revenue Q2 2013 · Jun 30, 2013 $24.67M
Revenue Q2 2013 · Jun 30, 2013 $48.29M
Revenue Q2 2013 · Jun 30, 2012 $11.11M
Revenue Q2 2013 · Jun 30, 2012 $19.11M